Skip to content

Insider · CIK 0001229447

David Smith V

director

Files at CDXS (CODEXIS, INC.), IOBT (IO Biotech, Inc.). First filing -, latest -.

David Smith V files SEC Form 4 as director at CDXS (CODEXIS, INC.), and also at IOBT (IO Biotech, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; David Smith V has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 17, 2026CDXS
CODEXIS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+66,350$0.00$066,350Jun 18, 2026
Jun 10, 2025CDXS
CODEXIS, INC.
AGrant or award
Common Stock
+40,983$0.00$0105,705Jun 12, 2025
Jun 5, 2025IOBT
IO Biotech, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+35,144$0.00$035,144Jun 6, 2025

Questions about David Smith V

Answered from the filings on this page, as of the latest one.

Is David Smith V buying or selling?

David Smith V has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did David Smith V's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Smith V has 0.

Where does David Smith V file Form 4?

David Smith V has filed Form 4 at CDXS (CODEXIS, INC.); IOBT (IO Biotech, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David Smith V: insider trades and track record | InsiderTell